Mazzocca et al. confirmed in vitro experiments that LPAR6 promoted the proliferation and tumorigenic phenotype of HCC cells, and established a relevant model to prove that LPAR6 promotes tumor growth, and the higher the expression level of LPAR6 in tumor tissues of liver cancer patients, the worse the prognosis of patients. This evidence concerns the gene LPAR6 and neoplasm.